|
2026
|
G/S
|
Pharmaceutical preparations for use against immune and inflammatory diseases |
|
|
G/S
|
Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,... |
|
|
G/S
|
Downloadable computer software for monitoring manufacturing processes in the pharmaceutical industry |
|
|
G/S
|
Pharmaceutical preparations for oncology |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological diseases |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic and renal diseases and... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy. |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy |
|
|
Invention
|
Enhanced septum retention for implanted ocular delivery systems.
An ophthalmic drug delivery dev... |
|
|
Invention
|
Lubricated fluid exchange needle for enhanced performance of refillable implantable ocular drug d... |
|
|
G/S
|
IC 010: Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devi... |
|
|
G/S
|
pharmaceutical preparations for use in oncology |
|
|
Invention
|
Methods of producing polypeptides using a cell line resistant to apoptosis.
Provided herein are ... |
|
|
Invention
|
Diagnostic and therapeutic methods for cancer.
Provided herein are diagnostic and therapeutic me... |
|
|
Invention
|
Compositions and methods for treating multiple sclerosis.
The present invention relates to metho... |
|
2025
|
Invention
|
Her2 heterogeneity as a biomarker in cancer.
A method for predicting responsiveness to a HER2-di... |
|
|
Invention
|
Methods and compositions for cancer treatment.
The present application provides methods of treat... |
|
|
Invention
|
Formulations with reduced degradation of polysorbate.
The invention provides methods for making ... |
|
|
Invention
|
System and method for cell-of-origin classification based on interpretable cellular features.
A ... |
|
|
Invention
|
Tie2-binding agents and methods of use.
The invention provides Tie-2 antibodies and fragments th... |
|
|
Invention
|
Macrophage signatures for diagnostic and therapeutic methods for lymphoma.
The present invention... |
|
|
Invention
|
Cell culture compositions and methods for polypeptide production.
Cell culture media, such as ch... |
|
|
Invention
|
Modified mammalian cells.
The present disclosure relates to methods, cells, and compositions for... |
|
|
Invention
|
Anti-cd79b antibodies and immunoconjugates and methods of use.
The present invention is directed... |
|
|
G/S
|
Downloadable computer software for health and medical data analysis and downloadable computer sof... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for early detection of cancer;... |
|
|
Invention
|
Methods and compositions for single-cell functional genomics. Aspects of the technology relate to... |
|
|
Invention
|
Machine learning-enabled analysis of protein sequences and generation of protein sequences therew... |
|
|
Invention
|
Eukaryotic cell media. This disclosure relates to eukaryotic cell culture media useful in the pro... |
|
|
Invention
|
Treatment of steatotic liver disease associated with metabolic dysfunction. The present disclosur... |
|
|
Invention
|
Treatment of steatotic liver disease associated with metabolic dysfunction.
The present disclosu... |
|
|
Invention
|
Neural network processing of oct data to generate predictions of geographic-atrophy growth rates.... |
|
|
Invention
|
Afucosylation modification. The present application relates to methods of producing a protein in ... |
|
|
Invention
|
Spatial feature analysis for digital pathology images.
Systems and methods relate to processing ... |
|
|
Invention
|
Multi-objective optimization for molecule design.
A plurality of molecule designs may be generat... |
|
|
Invention
|
Methods of treating multiple sclerosis with cd19-cd20 dual car-t cells. The present disclosure pr... |
|
|
Invention
|
Methods of treating lupus with cd19-cd20 dual car-t cells. e.g.e.g. highly active, severe, treatm... |
|
|
Invention
|
Managing clinical trial progression using machine learning-based data.
Systems and methods for m... |
|
|
Invention
|
Anti-interleukin-23 receptor vhh antibodies and uses thereof. Interleukin-23 receptor (IL23R) VHH... |
|
|
Invention
|
Machine learning enabled treatment response analysis using a cell density based computational pat... |
|
|
Invention
|
Machine learning enabled analysis of computed tomography and positron emission tomography scans f... |
|
|
Invention
|
Therapy for the treatment of non-hodgkin lymphoma. Provided herein are methods of treating and/or... |
|
|
Invention
|
Anti-cd20 antibody formulations. The present application relates to aqueous pharmaceutical formul... |
|
|
Invention
|
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy.
The present... |
|
|
Invention
|
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy. The present ... |
|
|
Invention
|
Synthesis of tert-butyl(lr,2s,5s)-2-((s)-l-hydroxyethyl)-2-methyl-3,8- diazabicyclo[3.2.1]octane-... |
|
|
Invention
|
Multicellular representations of single-cell transcriptomics for machine learning enabled patient... |
|
|
Invention
|
Polymeric particles for proximity-based cellular dna-encoded library screening and methods of use... |
|
|
Invention
|
Method of treating cancer using the kras g12d inhibitor gcd-7035. Provided herein are methods of ... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical pre... |
|
|
Invention
|
Heterocyclic compounds for the treatment of neurodegenerative diseases. Provided herein are compo... |
|
|
Invention
|
Lipid nanoparticles for delivery to the cns from systemic administration. in vivoin vivo in the c... |
|
|
Invention
|
Isoform-selective anti-tgf-beta antibodies and methods of use.
The invention provides isoform-se... |
|
|
Invention
|
Diagnostic method of determining the presence of a label-free antibody-antigen complex of interes... |
|
|
Invention
|
Cysteine engineered antibodies and conjugates.
Cysteine engineered antibodies comprising a free ... |
|
|
Invention
|
Process for the preparation of tricyclic pi3k inhibitor compounds and methods for using the same ... |
|
|
Invention
|
Pre-filled syringe with embedded filter.
Apparatus and methods for filtering syringe fluid conte... |
|
|
Invention
|
Anti-htra1 antibodies and methods of use thereof.
The present invention provides anti-HtrA1 anti... |
|
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
Invention
|
Methods of treating cancer using subcutaneous dosing of mosunetuzumab as a monotherapy or in comb... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Methods and compositions for classifying and treating bladder cancer.
The invention provides met... |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
2024
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
2023
|
Invention
|
Oxazepine compounds comprising a 6-aza moiety and uses thereof.
Provided herein are oxazepinyl c... |
|
2022
|
Invention
|
Methods and systems for gene alteration prediction from pathology slide images.
Described herein... |
|
|
Invention
|
Pharmaceutical composition comprising anti-pd-l1 antibody used in combination with anti-vegf anti... |
